Buparlisib hydrochloride

Ref. 3D-FB103659

Informations sur le produit

• Nom: Buparlisib hydrochloride
• Marque: Biosynth
• Description: Buparlisib hydrochloride is an experimental drug that inhibits the function of a protein called phosphoinositide 3-kinase (PI3K), which is involved in cell signaling pathways. The PI3K pathway plays a role in cancer development and progression, including tumor growth, invasiveness, and metastasis. Buparlisib hydrochloride is undergoing clinical trials for the treatment of cancers such as breast cancer and lung cancer. It has been found to have antitumor activity in vivo by inhibiting tumor tissue formation and inhibiting the growth of tumors that are resistant to hormone therapy.

Propriétés chimiques

• Masse moléculaire: 446.85 g/mol
• Formule: C₁₈H₂₁F₃N₆O₂•HCl
• Degré de pureté: Min. 95%